Evergreen Capital Management LLC Ab Cellera Biologics Inc. Transaction History
Evergreen Capital Management LLC
- $2.87 Billion
- Q4 2024
A detailed history of Evergreen Capital Management LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Evergreen Capital Management LLC holds 28,289 shares of ABCL stock, worth $85,715. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,289
Previous 11,902
137.68%
Holding current value
$85,715
Previous $30,000
173.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ABCL
# of Institutions
166Shares Held
120MCall Options Held
233KPut Options Held
339K-
Baker Bros. Advisors LP New York, NY27.5MShares$83.4 Million0.89% of portfolio
-
Baillie Gifford & CO12.2MShares$37.1 Million0.03% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$32.2 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA7.93MShares$24 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX7.35MShares$22.3 Million6.4% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $864M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...